For patients with high levels of renalase, after 20 days in the hospital, all had a 100 percent survival probability rate.
After about 40 days, the high-level group had a 65 percent chance of surviving and the low-level group had a 30 percent chance.
READ RELATED: Fears over fresh outbreak of Marburg virus that kills 90% of patients in Africa
Patients with the lowest levels were also more likely to die than those with higher levels of the blood protein.
Patients with low levels of renalase were also more likely to be treated with remdesivir, the drug approved for emergency use by the FDA.
Source: Daily Express
